kinase inhibitor

ADCs Make Their Mark in HER-Positive Cancers

ADCs Make Their Mark in HER-Positive Cancers

Members of the human epidermal growth factor receptor (HER) family, including HER1 (EGFR), HER2, HER3, and HER4, play central roles in regulating cell proliferation, survival, differentiation, and migration. Overexpression of […]

drug

Introduction to Marketed Kinase Inhibitors

In 2001, the FDA approved Imatinib, the first drug to be developed by targeting a specific protein kinase and the first molecularly targeted drug to fight cancer. It was considered […]

Science: Significant progress! Developed a new type of inflammatory inhibitor-small molecule OGG1 inhibitor

Inflammation Inflammation is a self-limiting, localized response to any tissue injury or trauma caused by wounding or infection, and is characterized by redness, heat, pain and swelling (rubor, calor, dolor, […]

The development of TRK inhibitors

Cancer treatment has entered the era of precision medicine, and an important feature of precision medicine is the selection of targeted drugs based on the patient’s tumor characteristics. In the […]

A Look at the Report of Globe Non-Tyrosine Kinase Inhibitor in Oncology, 2015-2025

A Look at the Report of Globe Non-Tyrosine Kinase Inhibitor in Oncology, 2015-2025

The report of non-tyrosine kinase inhibitor market in oncology in the period of 2015 to 2025 was released early in April of this year. Some of the data mentioned in […]